Abstract
Endocannabinoids (ECs) are characterized as the endogenous ligands of cannabinoid recep-tors (CRs). The research in the field of the endocannabinoid system (ECS) has forecasted a promising role that ECS could play in developing an understanding and management of nu-merous physiological disorders and several diseases. There is a range of analytical techniques that have proved to be fruitful in diagnosing and learning the metabolic and pathological role of these receptors/mediators through various
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have